Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| H-4-2013-070 | Other Identifier | The Danish National Committee on Biomedical Research Ethics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Copenhagen | OTHER |
| Arla Foods | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
From 3 interventiongroups in the project with ClinicalTrials.gov ID NCT02034760, namely:
HRTW: Heavy Strength Training x3/week & 20g whey protein twice daily. LITW: Light Intensity Training x3-5/week & 20g whey protein twice daily. WHEY: 20g whey protein twice daily.
15 subjects from each group will be recruited and tested after 3 months of intervention. Tests will include muscle cross sectional area (MRi), muscle biopsies (fiber types, size, cell- and capillary count), functional- and strength measurements, plasma lipids, HbA1c. Tests are to be compared with Project ID NCT01997320.
In- and exclusion criteria are listed in NCT02034760. Subjects will be randomized to interventions as described, and 15 subjects from each of the three groups will be tested after 12 weeks of intervention.
15 subjects are included in each group to account for an expected drop-out rate of 20%, and so 12 subjects are expected to complete each intervention. With this N an increase of around 11% in MRi-evaluated muscle size can be detected with a powerlevel of 80% and an alpha of 0.05 and use of reported SD.
Primary outcome is muscle size (MRi), and secondary outcomes are overall body composition (DXA), muscle strength, rate of force development, power, 30s chair stand, 400m gait speed, grip strength. Tertiary outcomes are habitual activitylevel (accelerometry), blood samples (HbA1c, cholesterols, creatinine), blood pressure, weight, BMI, wast- and hip circumference.
Results are to be compared with NCT01997320 and so a population of 65+ can be compared with a population of 83+. Both studies uses the same heavy strength training regimen.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Heavy Resistance Training | Active Comparator | Heavy Resistance Training of the lower extremities three times weekly in combination with two daily 20g whey protein and 10g carbohydrate supplementations for 3 months. |
|
| Light Intensity Training | Experimental | Home-based Light Intensity Training of the lower extremities three-five times weekly in combination with two daily 20g whey protein and 10g carbohydrate supplementations for 3 months. |
|
| Protein Whey | Active Comparator | Two daily 20g whey protein and 10g carbohydrate supplementations for 3 months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Heavy Resistance Training | Procedure | Supervised Heavy Resistance Training three times weekly for 3 months. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in muscle cross sectional area | MRi scans of quadriceps muscle cross sectional area. The statistical evaluation of the primary outcome measure is done by applying a two way ANOVA test comparing groups: 1) Heavy Resistance Training vs. Light Intensity Training vs. Protein Whey. The statistical evaluation will be performed first as an intension-to-treat analysis and subsequently as a per-protocol analysis. | Baseline, 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in quadriceps muscle isometric strength | Isometric unilateral quadriceps force and rate of force development measured in the isokinetic dynamometer device (KinCom) during knee extension at the knee angle 70 deg (with 0 degrees being fully extended). | Baseline, 3 months |
| Change in quadriceps muscle isokinetic strength |
| Measure | Description | Time Frame |
|---|---|---|
| Change in blood parameters and anthropometry | Blood: HbA1c, plasma lipids. Anthropometry: Weight, abdominal circumference. Blood pressure. | Baseline, 3 months |
| Change in gait speed | 400 m gait speed. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rasmus Bechshøft, Ph.d. | Bispebjerg Hospital | Principal Investigator |
| Lars Holm, Assoc. prof. | Bispebjerg Hospital | Principal Investigator |
| Michael Kjær, MD, Proff. | Bispebjerg Hospital | Principal Investigator |
| Søren Reitelseder, Ph.d. | Bispebjerg Hospital | Principal Investigator |
| Jacob Bülow, MD PhD stud | Bispebjerg Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bispbebjerg Hospital | Copenhagen NV | 2400 | Denmark |
Yes, full data set will be available online.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D055948 | Sarcopenia |
| D009133 | Muscular Atrophy |
| D000073496 | Frailty |
| ID | Term |
|---|---|
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D001284 | Atrophy |
Not provided
Not provided
| ID | Term |
|---|---|
| D000067796 | Whey |
| ID | Term |
|---|---|
| D008892 | Milk |
| D001628 | Beverages |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Light Intensity Training | Procedure | Home-based Light Intensity Training three-five times weekly for 3 months. |
|
| Protein Whey | Procedure | Two daily 20g whey protein and 10g carbohydrate supplementations for 3 months. |
|
Unilateral knee extension (concentric) strength measured in the KinCom device at an angular velocity of 60 degrees/sec. |
| Baseline, 3 months |
| Change in leg extension muscle power | Unilateral leg extension power measured in the Powerrig device. | Baseline, 3 months |
| Change from baseline in muscle structure and signalling | From muscle biopsies muscle fiber type distribution and size, capillary density, satellite cell count and activity, selected gene-expression targets and protein concentrations will be assessed. | Baseline and 3 months |
| Change in 30 s chair stand | Number of stand-ups from a chair in 30 seconds. | Baseline, 3 months |
| Change in whole body composition and bone mineral density | Body composition (fat mass, lean mass and bone mass) evaluated by whole-body dual energy x-ray absorptiometry (DXA)-scanning. Bone mineral density at dominant collum femoris and vertebrae L2-L4 evaluated by DXA-scanning. | Baseline, 3 months |
| Baseline, 3 months |
| Change in grip strength | Isometric hand grip strength. | Baseline, 3 months |
| Questionnaires and interviews | Short Form 36 | Baseline, 3 months |
| Change in habitual activity | Evaluated by 4 days continuous monitoring by a pedometer device (ActivPal). | Baseline, 3 months |
| Change in daily macronutrient intake | 4-days self-report of food and beverage intake. | Baseline, 1,5 months |
| D020763 |
| Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |
| D010335 | Pathologic Processes |
| D003611 |
| Dairy Products |
| D005502 | Food |
| D019602 | Food and Beverages |